title: Continuous subcutaneous insulin infusion to resolve an allergy to human insulin.
authors.forename: Silvia
authors.initials: S
authors.lastname: Näf
authors.forename: Enric
authors.initials: E
authors.lastname: Esmatjes
authors.forename: Mónica
authors.initials: M
authors.lastname: Recasens
authors.forename: Antonio
authors.initials: A
authors.lastname: Valero
authors.forename: Irene
authors.initials: I
authors.lastname: Halperin
authors.forename: Isaac
authors.initials: I
authors.lastname: Levy
authors.forename: Ramón
authors.initials: R
authors.lastname: Gomis
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000517:prevention & control*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D007332:Insulin Infusion Systems; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D007328:Insulin; D011994:Recombinant Proteins; D007073:Immunoglobulin E